← Leaderboards
Jeffery Alexander
Paxvax, Inc.
$1,764,192
Attributed
$5,292,575
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–16$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,292,575 · 3
By mechanism
R44$4,743,753 · 2
R43$548,822 · 1
Top collaborators
- Marc Joseph Gurwith7 shared
- Jonathan Smith4 shared
- Timothy Mayall3 shared
Most similar at Paxvax, Inc.
Same institution · by research overlap
- Marc Joseph Gurwith$21,974,740
- Timothy Mayall$894,281
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventProductionNovel StrategiesPoliomyelitisNeutralizing AntibodyMeasles VaccineImmune ResponseImmunizationOral CavityOryctolagus CuniculusIn VitroLifeAcquired Immunodeficiency SyndromeEvaluationAnimalsHiv-1AntigensEnv Gene ProductsBaseGlycoproteinsAdenovirusesImmunogenicityAntibodiesPrograms
Grant awards (7)
HIV B-Cell Lineage Vaccine Design Based on Replicating SAd and Env Protein in NHP$971,055
R44 · FY2016 · AI · contact PI
HIV B-Cell Lineage Vaccine Design Based on Replicating SAd and Env Protein in NHP$801,463
R44 · FY2015 · AI · contact PI
Oral, replicating Ad4-HIV vaccine development & evaluation in NHP challenge model$971,235
R44 · FY2014 · AI
Oral, replicating Ad4-HIV vaccine development & evaluation in NHP challenge model$1,000,000
R44 · FY2013 · AI
Replicating Ad4-HIV vaccine development based on improved HIV Env and GBV-C E2$287,214
R43 · FY2013 · AI · contact PI
Oral, replicating Ad4-HIV vaccine development & evaluation in NHP challenge model$1,000,000
R44 · FY2012 · AI
Replicating Ad4-HIV vaccine development based on improved HIV Env and GBV-C E2$261,608
R43 · FY2012 · AI · contact PI